✕
Sections
The Harvard Crimson Logo

News

Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil

News

Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum

News

Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta

News

After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct

News

Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds

By Andrew B. Pacelli
Charles P. Ducey, director of the Bureau of Study Counsel, spoke yesterday about the political power the psychopharmacological industry wields through congressional lobbying during a panel discussion in Sever Hall.
Charles P. Ducey, director of the Bureau of Study Counsel, spoke yesterday about the political power the psychopharmacological industry wields through congressional lobbying during a panel discussion in Sever Hall.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags

Related Articles

Harvard Experts Evaluate Mental Health Medications